Family Medicine Doctors in Belfast, ME Accepting Medicare

19 Family Medicine doctors found. Showing 1 - 19

Matthew Scott Molison, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-930-6708    Fax: 207-930-6709

Susan Miller, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500

Alan C Carter, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 9 Fahy St, Belfast, ME 04915 Phone: 207-505-4970

Christine L Kramer, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900    Fax: 207-338-4976

Kaitlyn Ryan Lamarche, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500

Dr. Benjamin Bruce Mailloux, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Fahey St, Suite 103, Belfast, ME 04915 Phone: 207-338-5440    Fax: 207-338-6912

David A Thanhauser, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 75 Northport Ave, Belfast, ME 04915 Phone: 207-338-3995

Nicole C Rausch, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900    Fax: 207-338-4974

Brett C Powers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900    Fax: 207-338-4974

Thomas Roland Maycock, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9 Fahey St, Belfast, ME 04915 Phone: 207-338-1120    Fax: 207-338-1691

Dr. Megan R Britton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500

Dr. Jeffrey W Newsom, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Northport Ave, Belfast, ME 04915 Phone: 207-930-6708    Fax: 207-930-6709

Dr. Lazarus Onwuka, D.O., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-661-2018

Leigh Presutto, Family Medicine Medicare: Medicare Enrolled Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-338-2500

Heather M Ward, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9 Fahey St, Belfast, ME 04915 Phone: 207-338-1120    Fax: 207-338-1691

Timothy Hughes, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900    Fax: 207-338-4976

Peter S Millard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900

Carol Kuhn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900    Fax: 207-338-4976

Jennifer C Eaton, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900

News Archive

Pregis Corporation announces Q2 2009 financials

Pregis Corporation, a leading international manufacturer, marketer, and supplier of protective packaging products and specialty packaging solutions, today announced its 2009 second quarter financial results.

Baxter institutes Baxter Ventures to invest $200M in promising early-stage therapies

Baxter International Inc. announced today that it has established Baxter Ventures to invest up to $200 million in equity in promising early-stage companies developing therapies that complement Baxter's existing portfolio.

Hydroxychloroquine shown to slow recovery for COVID-19 patients

As researchers try to piece together a therapeutic strategy against the ongoing COVID-19 pandemic, a recent retrospective study from Cleveland Clinic Abu Dhabi, assessed the Hydroxychloroquine's efficacy in increasing SARS-CoV-2 viral clearance, finding that it appeared to significantly slow viral clearance in mild to moderately ill COVID-19 patients.

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of hemophilia and rare bleeding disorders.

Read more Medical News

› Verified 5 days ago